TY - JOUR
T1 - The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance
AU - Rota, Paul A.
AU - Evans, Roger
AU - Ben Mamou, Myriam Corinne
AU - Rey-Benito, Gloria
AU - Sangal, Lucky
AU - Dosseh, Annick
AU - Ghoniem, Amany
AU - Byabamazima, Charles R.
AU - Demanou, Maurice
AU - Anderson, Raydel
AU - Kim, Gimin
AU - Bankamp, Bettina
AU - Beard, R. Suzanne
AU - Crooke, Stephen N.
AU - Ramachandran, Sumathi
AU - Penedos, Ana
AU - Stambos, Vicki
AU - Nicholson, Suellen
AU - Featherstone, David
AU - Mulders, Mick N.
N1 - Publisher Copyright:
© 2024 by the authors.
PY - 2024/8
Y1 - 2024/8
N2 - With 762 laboratories, the Global Measles and Rubella Laboratory Network (GMRLN) is the largest laboratory network coordinated by the World Health Organization (WHO). Like the Global Polio Laboratory Network, the GMRLN has multiple tiers, including global specialized laboratories, regional reference laboratories, national laboratories, and, in some countries, subnational laboratories. Regional networks are supervised by regional laboratory coordinators reporting to a global coordinator at WHO headquarters. Laboratories in the GMRLN have strong links to national disease control and vaccination programs. The GMRLN’s goal is to support member states in obtaining timely, complete, and reliable laboratory-based surveillance data for measles and rubella as part of the strategy for achieving measles and rubella elimination. Surveillance data are reported to the national program and are included in annual reports on the status of measles and rubella elimination to national verification committees for review by regional verification commissions. Quality within the GMRLN is ensured by monitoring performance through external quality assurance programs, confirmatory and quality control testing, accreditation, and coordination of corrective action and training where needed. The overall performance of the laboratories has remained high over the years despite many challenges, particularly the COVID-19 pandemic. The GMRLN is well-positioned to support high-quality laboratory-based surveillance for measles and rubella and to transition to supporting laboratory testing for other pathogens, including vaccine-preventable diseases.
AB - With 762 laboratories, the Global Measles and Rubella Laboratory Network (GMRLN) is the largest laboratory network coordinated by the World Health Organization (WHO). Like the Global Polio Laboratory Network, the GMRLN has multiple tiers, including global specialized laboratories, regional reference laboratories, national laboratories, and, in some countries, subnational laboratories. Regional networks are supervised by regional laboratory coordinators reporting to a global coordinator at WHO headquarters. Laboratories in the GMRLN have strong links to national disease control and vaccination programs. The GMRLN’s goal is to support member states in obtaining timely, complete, and reliable laboratory-based surveillance data for measles and rubella as part of the strategy for achieving measles and rubella elimination. Surveillance data are reported to the national program and are included in annual reports on the status of measles and rubella elimination to national verification committees for review by regional verification commissions. Quality within the GMRLN is ensured by monitoring performance through external quality assurance programs, confirmatory and quality control testing, accreditation, and coordination of corrective action and training where needed. The overall performance of the laboratories has remained high over the years despite many challenges, particularly the COVID-19 pandemic. The GMRLN is well-positioned to support high-quality laboratory-based surveillance for measles and rubella and to transition to supporting laboratory testing for other pathogens, including vaccine-preventable diseases.
KW - diagnostics
KW - measles-rubella laboratory
KW - network
KW - PCR
KW - serology
KW - WHO
UR - http://www.scopus.com/inward/record.url?scp=85202438358&partnerID=8YFLogxK
U2 - 10.3390/vaccines12080946
DO - 10.3390/vaccines12080946
M3 - Article
AN - SCOPUS:85202438358
SN - 2076-393X
VL - 12
JO - Vaccines
JF - Vaccines
IS - 8
M1 - 946
ER -